Ideally, these scans are used when blood tests suggest a rise in a certain tumor marker and the patient is known to be responsive to radioactive iodine treatment.
My goal is to understand how and why a person may or may not respond to therapy by evaluating certainmarkers — genetic changes, proteins, and other features — in blood or tumor tissue.